BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29536748)

  • 21. Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.
    Turri-Zanoni M; Salzano G; Lambertoni A; Giovannardi M; Karligkiotis A; Battaglia P; Castelnuovo P
    Head Neck; 2017 Apr; 39(4):730-736. PubMed ID: 28032937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater.
    Cloyd JM; Wang H; Overman M; Zhao J; Denbo J; Prakash L; Kim MP; Shroff R; Javle M; Varadhachary GR; Fogelman D; Wolff RA; Koay EJ; Das P; Maitra A; Aloia TA; Vauthey JN; Fleming JB; Lee JE; Katz MHG
    Ann Surg Oncol; 2017 Jul; 24(7):2031-2039. PubMed ID: 28124275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term results of surgical treatment of Vater's ampulla neoplasms.
    Bucher P; Chassot G; Durmishi Y; Ris F; Morel P
    Hepatogastroenterology; 2007 Jun; 54(76):1239-42. PubMed ID: 17629078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective Experience.
    Demirci NS; Cavdar E; Ozdemir NY; Yuksel S; Iriagac Y; Erdem GU; Odabas H; Hacibekiroglu I; Karaagac M; Ucar M; Ozturk B; Bozkaya Y
    Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38793001
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of lymph nodes in predicting the prognosis of ampullary carcinoma after curative resection.
    Chen SC; Shyr YM; Chou SC; Wang SE
    World J Surg Oncol; 2015 Jul; 13():224. PubMed ID: 26205252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio (PLT-PLR) in patients with surgically resected non-small cell lung cancer.
    Kim SH; Lee HW; Go SI; Lee SI; Lee GW
    Oncotarget; 2016 Jun; 7(24):36198-36206. PubMed ID: 27105529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value of Excision Repair Cross-Complementing Gene 1, Dihydropyrimidine Dehydrogenase, and Human Equilibrative Nucleotide Transporter 1 Expression and Their Implications for Adjuvant Treatment in Patients With Ampullary Carcinoma.
    Kawabata Y; Nishi T; Kidani A; Tajima Y
    Pancreas; 2015 Aug; 44(6):937-44. PubMed ID: 25906447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
    Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
    Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological and operative factors for prognosis of carcinoma of the ampulla of vater.
    Inoue Y; Hayashi M; Hirokawa F; Egashira Y; Tanigawa N
    Hepatogastroenterology; 2012; 59(117):1573-6. PubMed ID: 22683975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic impact of histological blood vessel invasion in patients with ampullary adenocarcinoma.
    Kawaguchi T; Ochiai T; Ikoma H; Inoue K; Morimura R; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Okamoto K; Fujiwara H; Kokuba Y; Sonoyama T; Otsuji E
    Hepatogastroenterology; 2010; 57(104):1347-50. PubMed ID: 21443083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
    Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
    J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma.
    Schwarz RE; Keny H
    Hepatogastroenterology; 2001; 48(41):1493-8. PubMed ID: 11677994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinoma of the ampulla of Vater: long-term survival after surgical treatment.
    Wei TC; Yu SC; Lee PH; Hsu SC
    J Formos Med Assoc; 1993 Jul; 92(7):632-7. PubMed ID: 7904499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinoma of the ampulla of Vater: results of surgical treatment of a single center.
    Memon MA; Shiwani MH; Anwer S
    Hepatogastroenterology; 2004; 51(59):1275-7. PubMed ID: 15362731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological factors influencing survival of carcinoma of the ampulla of Vater.
    Mori K; Ikei S; Yamane T; Yamaguchi Y; Katsumori T; Shibata Y; Arai T
    Eur J Surg Oncol; 1990 Jun; 16(3):183-8. PubMed ID: 2347413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative Endoscopic Biliary Drainage May Negatively Impact Survival Following Pancreatoduodenectomy for Ampullary Cancer.
    Barauskas G; Urbonas K; Smailyte G; Pranys D; Pundzius J; Gulbinas A
    Dig Surg; 2016; 33(6):462-9. PubMed ID: 27230404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater.
    Todoroki T; Koike N; Morishita Y; Kawamoto T; Ohkohchi N; Shoda J; Fukuda Y; Takahashi H
    Ann Surg Oncol; 2003 Dec; 10(10):1176-83. PubMed ID: 14654474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical outcomes and prognostic factors for ampulla of Vater cancer.
    Choi SB; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
    Scand J Surg; 2011; 100(2):92-8. PubMed ID: 21737384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma.
    Kim RD; Kundhal PS; McGilvray ID; Cattral MS; Taylor B; Langer B; Grant DR; Zogopoulos G; Shah SA; Greig PD; Gallinger S
    J Am Coll Surg; 2006 Jan; 202(1):112-9. PubMed ID: 16377504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: A retrospective monocentric study on 153 patients.
    Messager M; Neofytou K; Chaudry MA; Allum WH
    Eur J Surg Oncol; 2015 Oct; 41(10):1316-23. PubMed ID: 26166786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.